Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Orth

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
Biomedicines|April 23, 2022
Longitudinal [<sup>18</sup>F]GE-180 PET Imaging Facilitates In Vivo Monitoring of TSPO Expression in the GL261 Glioblastoma Mouse ModelAdrien Holzgreve, Dennis Pötter, Matthias Brendel, et al.
NPJ Genomic Medicine|September 6, 2022
Huntington's disease age at motor onset is modified by the tandem hexamer repeat in TCERG1Sergey V Lobanov, Branduff McAllister, Mia McDade-Kumar, et al.
Experimental Hematology & Oncology|February 15, 2017
A randomized exploratory phase 2 study in patients with chemotherapy-related peripheral neuropathy evaluating whole-body vibration training as adjunct to an integrated program including massage, passive mobilization and physical exercisesStefan S Schönsteiner, Heidi Bauder Mißbach, Axel Benner, et al.
Human Brain Mapping|August 2, 2016
Natural variation in sensory-motor white matter organization influences manifestations of Huntington's diseaseMichael Orth, Sarah Gregory, Rachael I Scahill, et al.
Cancer Letters|November 22, 2016
Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevanceJulia Hess, Kristian Unger, Michael Orth, et al.
Plos Genetics|May 12, 2018
Population-specific genetic modification of Huntington's disease in VenezuelaMichael J Chao, Kyung-Hee Kim, Jun Wan Shin, et al.
American Journal of Human Genetics|June 27, 2020
Genetic and Functional Analyses Point to FAN1 as the Source of Multiple Huntington Disease Modifier EffectsKyung-Hee Kim, Eun Pyo Hong, Jun Wan Shin, et al.
Biomed Research International|December 8, 2017
Linked Registries: Connecting Rare Diseases Patient Registries through a Semantic Web LayerPedro Sernadela, Lorena González-Castro, Claudio Carta, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2024
Posttranscriptional regulation of <i>FAN1</i> by miR-124-3p at rs3512 underlies onset-delaying genetic modification in Huntington's diseaseKyung-Hee Kim, Eun Pyo Hong, Yukyeong Lee, et al.
Human Molecular Genetics|January 10, 2018
CHCHD10 mutations p.R15L and p.G66V cause motoneuron disease by haploinsufficiencySarah J Brockmann, Axel Freischmidt, Patrick Oeckl, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Biomedicines|April 23, 2022
Longitudinal [<sup>18</sup>F]GE-180 PET Imaging Facilitates In Vivo Monitoring of TSPO Expression in the GL261 Glioblastoma Mouse ModelAdrien Holzgreve, Dennis Pötter, Matthias Brendel, et al.
NPJ Genomic Medicine|September 6, 2022
Huntington's disease age at motor onset is modified by the tandem hexamer repeat in TCERG1Sergey V Lobanov, Branduff McAllister, Mia McDade-Kumar, et al.
Experimental Hematology & Oncology|February 15, 2017
A randomized exploratory phase 2 study in patients with chemotherapy-related peripheral neuropathy evaluating whole-body vibration training as adjunct to an integrated program including massage, passive mobilization and physical exercisesStefan S Schönsteiner, Heidi Bauder Mißbach, Axel Benner, et al.
Human Brain Mapping|August 2, 2016
Natural variation in sensory-motor white matter organization influences manifestations of Huntington's diseaseMichael Orth, Sarah Gregory, Rachael I Scahill, et al.
Cancer Letters|November 22, 2016
Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevanceJulia Hess, Kristian Unger, Michael Orth, et al.
Plos Genetics|May 12, 2018
Population-specific genetic modification of Huntington's disease in VenezuelaMichael J Chao, Kyung-Hee Kim, Jun Wan Shin, et al.
American Journal of Human Genetics|June 27, 2020
Genetic and Functional Analyses Point to FAN1 as the Source of Multiple Huntington Disease Modifier EffectsKyung-Hee Kim, Eun Pyo Hong, Jun Wan Shin, et al.
Biomed Research International|December 8, 2017
Linked Registries: Connecting Rare Diseases Patient Registries through a Semantic Web LayerPedro Sernadela, Lorena González-Castro, Claudio Carta, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2024
Posttranscriptional regulation of <i>FAN1</i> by miR-124-3p at rs3512 underlies onset-delaying genetic modification in Huntington's diseaseKyung-Hee Kim, Eun Pyo Hong, Yukyeong Lee, et al.
Human Molecular Genetics|January 10, 2018
CHCHD10 mutations p.R15L and p.G66V cause motoneuron disease by haploinsufficiencySarah J Brockmann, Axel Freischmidt, Patrick Oeckl, et al.
Pageof 15